Current pathways for epidemiological research in amyotrophic lateral sclerosis

References

• Armon C. An evidence based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003;22: 217–28.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. J Neurol Sci. 1994;(Suppl); S96–107.
   PubMedGoogle Scholar
• McGuire V, Nelson LM. Epidemiology of ALS. In: Mitsumoto H, Przedborski S, Gordon PH, editors. Amyotrophic Lateral Sclerosis. New York: Taylor and Francis; 2006. pp 17–41.
   Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell, JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
   PubMed Web of Science ®Google Scholar
• O’Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30–2.
   PubMed Web of Science ®Google Scholar
• Donaghy C, O’Toole O, Sheehan C, Kee F, Hardiman O, Patterson V. An all-Ireland epidemiological study of MND, 2004 − 2005. Eur J Neurol. 2009;16:148–53.
   PubMed Web of Science ®Google Scholar
• Yeo L, Lynch C, Hardiman O. Validating population based registries for ALS: how accurate is death certification? J Neurol. 2010:257:1235–9.
   PubMed Web of Science ®Google Scholar
• Donaghy C, Clarke J, Patterson C, Kee F, Hardiman O, Patterson V, et al. The epidemiology of motor neuron disease in Northern Ireland using capture-recapture methodology. Amyotroph Lateral Scler. 2010;11:374–8.
   PubMed Web of Science ®Google Scholar
• Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2012;83:102–8.
   PubMed Web of Science ®Google Scholar
• Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011; 76:1263–9.
   PubMed Web of Science ®Google Scholar
• Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population based mortality study. Neurology. 2009;72:1640–5.
   PubMed Web of Science ®Google Scholar
• Cronin S, Hardiman O, Traynor B. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007;68:1002–7.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–40.
   PubMed Web of Science ®Google Scholar
• Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell RW, Howard R, et al. Amyotrophic lateral sclerosis in south-east England: a population based study. The south-east England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology. 2007;29:44–8.
   PubMed Web of Science ®Google Scholar
• Beghi E, Logroscino G, Chiò A, Hardiman O, Mitchell D, Swingler R, et al. The epidemiology of ALS and the role of population based registries. Biochim Biophys Acta. 2006;1762:1150–7.
   PubMed Web of Science ®Google Scholar
• Huisman MH, de Jong SW, van Doormaal PT, Weinreich SS, Schelhaas HJ, van der Kooi AJ, et al. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry. 2011;82:1165–70.
   PubMed Web of Science ®Google Scholar
• Forbes RB, Colville S, Parratt J, Swingler RJ. Incidence of motor neuron disease in Scotland. J Neurol. 2007;254: 866–9.
   PubMed Web of Science ®Google Scholar
• Armon C. Sports and trauma in amyotrophic lateral sclerosis revisited. J Neurol Science. 2007;262:45–53.
   PubMed Web of Science ®Google Scholar
• Chia A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R, et al. Epidemiology of ALS in Italy: a 10-year prospective population based study. Neurology. 2009;72: 725–31.
   PubMedGoogle Scholar
• Johnston CA, Stanton BR, Turner MR, Gray R, Blunt AHM, Butt D, et al. Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. J Neurol. 2006;253:1642–3.
   PubMed Web of Science ®Google Scholar
• Hanby MF, Scott KM, Scotton W, Wijesekera L, Mole T, Ellis CE, et al. The risk to relatives of patients with sporadic amyotrophic lateral sclerosis. Brain. 2011;134:3454–7.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Lewis CM. Modeling the effects of penetrance and family size on rates of sporadic and familial disease. Human Heredity. 2011;7:281–8.
   Google Scholar
• Okamoto K, Kobashi G, Washio M, Sasaki S, Yokoyama T, Miyake Y, et al. Descriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995– 2001. J Epidemiol.2005;11: 1520–3.
   Google Scholar
• Doi Y, Yokoyama T, Tango T, Takahashi K, Fujimoto K, Nakano I. Temporal trends and geographic clusters of mortality from amyotrophic lateral sclerosis in Japan, 1995–2004. J Neurol Sci. 2010;298:78–84.
   PubMed Web of Science ®Google Scholar
• Atsuta N, Watanabe H, Ito M, Tanaka F, Tamakoshi A, Nakano I, et al. Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. J Neurol Sci. 2009;276:163–9.
   PubMed Web of Science ®Google Scholar
• Garruto RM, Yanagihara R, Gajdusek DC. Disappearance of high incidence amyotrophic lateral sclerosis and Parkinsonism-dementia on Guam. Neurology. 1985;35:193–8.
   PubMed Web of Science ®Google Scholar
• Garruto RM. Pacific paradigms of environmentally induced neurological disorders: clinical, epidemiological and molecular perspectives. NeuroToxicology. 1991;12:347–8.
   PubMed Web of Science ®Google Scholar
• Plato CC, Garruto RM, Galasko D, Craig UK, Plato M, Gamst A, et al. Amyotrophic lateral sclerosis and Parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Amer J Epidemiol. 2003;157:149–57.
   PubMed Web of Science ®Google Scholar
• Kihira T, Yoshida S, Kondo T, Iwai K, Wada S, Morinaga S, et al. An increase in ALS incidence on the Kii Peninsula, 1960−2009: a possible link to change in water source. Amyotroph Lateral Scler. 2012:13:347–50.
   PubMed Web of Science ®Google Scholar
• Kuzuhara S, Kokubo Y. Atypical Parkinsonism of Japan: Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia complex of the Kii Peninsula of Japan (Muro Disease): An update. Movement Disorders. 2005;20(Suppl 12):S108–13.
   PubMedGoogle Scholar
• Strong MJ, Wolff AV, Wakayama I, Garruto RM. Aluminum-induced chronic myelopathy in rabbits. NeuroToxicology. 1991;12:9–22.
   PubMed Web of Science ®Google Scholar
• Lynch D, Wanglund C, Spathis R, Chan CW, Reiff DM, Lum JK, et al. The contribution of mitochondrial dysfunction to a gene-environment model of Guamanian ALS and PD. Mitochondrion. 2007;8:109–16.
   PubMedGoogle Scholar
• Reiff DM, Spathis R, Chan CW, Vilar MG, Sankaranarayanan K, Lynch C, et al. Inherited and somatic mitochondrial DNA in Guam amyotrophic lateral sclerosis and Parkinsonism-dementia. Neurological Sciences. 2011; 32:883–92.
   PubMed Web of Science ®Google Scholar
• Hermosura MC, Garruto RM. TRPM7 and TRPM2 – candidate susceptibility genes for western Pacific ALS and PD? Biochimica et Biophysica Acta. 2007;1772:822–35.
   PubMed Web of Science ®Google Scholar
• Hara K, Kokubo Y, Ishiura H, Fukuda Y, Miyashita A, Kuwano R, et al. TRPM7 Is Not Associated With Amyotrophic Lateral Sclerosis-Parkinsonism Dementia Complex in the Kii Peninsula of Japan. Am J Med Genet Part B. 2010;153:310–3.
   Google Scholar
• Bradley WG, Cox PA. Beyond Guam: BMAA and sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;(Suppl 2):1–126.
   PubMed Web of Science ®Google Scholar
• Murch SJ, Cox PA, Banack SA. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. PNAS. 2004;101:12228–31.
   PubMed Web of Science ®Google Scholar
• Pablo J, Banack SA, Cox PA, Johnson TE, Papapetropoulos S, Bradley WG, et al. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurol Scand. 2009; 120:216–225.
   PubMed Web of Science ®Google Scholar
• Brand LE, Pablo J, Compton A, Hammerschlag N, Mash DC. Cyanobacterial blooms and the occurrence of the neurotoxin beta-N-methylamino-L-alanine (BMAA) in South Florida aquatic food webs. Harmful Algae. 2010; 2:620–35.
   Google Scholar
• Caller TA, Doolin JW, Haney JF, Murby AJ, West KG, Farrar HE, et al. A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms. Amyotrph Lateral Scler. 2009;10(Suppl 2):101–8.
   PubMed Web of Science ®Google Scholar
• Caller TA, Field NC, Chipman JW, Shi X, Harris BT, Stommel EW. Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA. Amyotroph Lateral Scler. 2012;13:25–32.
   PubMed Web of Science ®Google Scholar
• Horner RD, Grambow SC, Coffman CJ, Lindquist JH, Oddone EZ, Allen KD, et al. Amyotrophic lateral sclerosis among 1991 Gulf War veterans: evidence for a time-limited outbreak. Neuroepidemiology. 2008;31:28–32.
   PubMed Web of Science ®Google Scholar
• Weisskopf MG, O’Reilly EJ, McCullough ML, Calle EE, Thun MJ, Cudkowicz , et al. Prospective study of military service and mortality from ALS. Neurology. 2005;64:32–7.
   PubMed Web of Science ®Google Scholar
• IOM (Institute of Medicine). Gulf War and Health, Volume 8: Update of Health Effects of Serving in the Gulf War. Washington, DC: The National Academies Press, 2010.
   Google Scholar
• Nelson LM, van den Eeden SK, Tanner CM, Bernstein AL. Incidence of amyotrophic lateral sclerosis in a multiethnic health care organization. Neuroepidemiology. 2010;34:276.
   Google Scholar
• Albers K, Nelson LM, Tanner CM, McGuire V, Popat R, Bernstein AL, et al. Lead exposure and amyotrophic lateral sclerosis in a northern California population. 61st Annual Meeting of the American Academy of Neurology, World Federation of Neurology (Seattle, WA, 25 April − 2 May). 2009 PM(C)ID: none.
   Google Scholar
• Weisskopf MG, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, Ascherio A. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol. 2004;160:26–33.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Weisskopf MG, O’Reilly EJ, Jacobs EJ, McCullough ML, Calle EE, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann Neurol. 2005; 57:104–10.
   PubMed Web of Science ®Google Scholar
• Wang H, O’Reilly ÉJ, Weisskopf MG, Logroscino G, McCullough ML, Schatzkin A, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from five prospective studies. Amer J Epidemiol. 2011;173:595–602.
   PubMed Web of Science ®Google Scholar
• Wang H, O’Reilly EJ, Weisskopf MG, Logroscino G, McCullough ML, Thun MJ, et al. Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of five prospective cohorts. Arch Neurol. 2011;68:207–13.
   PubMed Web of Science ®Google Scholar
• Fang F, Bellocco R, Hernan MA, Ye WM. Smoking, snuff dipping and the risk of amyotrophic lateral sclerosisL a prospective cohort study. Neuroepidemiology. 2006;27: 217–21.
   PubMed Web of Science ®Google Scholar
• Kamel F, Umbach DM, Munsat TL, Shefner JM, Hu H, Sandler DP.. Lead exposure and amyotrophic lateral sclerosis. Epidemiology. 2002;13:311–9.
   PubMed Web of Science ®Google Scholar
• Kamel F, Umbach DM, Munsat TL, Shefner JM, Sandler DP.. Association of cigarette smoking with amyotrophic lateral sclerosis. Neuroepidemiology. 1999; 18:194–202.
   PubMed Web of Science ®Google Scholar
• Chen H, Richard M, Sandler DP, Umbach DM, Kamel F. Head injury and amyotrophic lateral sclerosis. Amer J Epidemiol. 2007;166:810–6.
   PubMed Web of Science ®Google Scholar
• Fang F, Quinlan P, Ye W, Barber MK, Umbach DM, Sandler DP, et al. Workplace exposures and the risk of amyotrophic lateral sclerosis. Environ Health Perspect. 2009; 117:1387–92.
   PubMed Web of Science ®Google Scholar
• Fang F, Kwee LC, Allen KD, Umbach DM, Ye WM, Watson M, et al. Association between blood lead and the risk of amyotrophic lateral sclerosis. Amer J Epidemiol. 2010;171:1126–33.
   PubMed Web of Science ®Google Scholar
• McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy following repetitive head injury. J Neuropath Exp Neurol. 2009;68: 709–35.
   PubMed Web of Science ®Google Scholar
• Chio A, Calvo A, Dossena M, Ghiglione P, Mutani R, Mora G. ALS in Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph Lateral Scler. 2009;10:205–9.
   PubMed Web of Science ®Google Scholar
• McKee A, Gavett BE, Stern R, Nowinski CJ, Cantu RC, Kowall NW, et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropath Exp Neurol. 2010;69:918–29.
   PubMed Web of Science ®Google Scholar
• Gavett B, Stern R, Cantu R, Nowinski CJ, McKee AC. Mild traumatic brain injury: a risk factor for neurodegeneration. Alzheimer's Research and Therapy. 2010;2:18.
   PubMed Web of Science ®Google Scholar
• Alonso A, Logroscino G, Jick SS, Hernan MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population based study. Eur J Neurol. 2009;16:745–51.
   PubMed Web of Science ®Google Scholar
• Byrne S, Elamin M, Bede P, Hardiman O. Absence of consensus in diagnostic criteria for familial neurodegenerative diseases. Journal of Neurology, Neurosurgery, and Psychiatry. 2012;83:365–7. Epub 2012/03/09. PubMed PMID: 22399794.
   PubMed Web of Science ®Google Scholar
• Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology. 1986;36:511–7.
   PubMed Web of Science ®Google Scholar
• Williams DB, Floate DA, Leicester J. Familial motor neuron disease: differing penetrance in large pedigrees. J Neurol Sci. 1988;86:215–30.
   PubMed Web of Science ®Google Scholar
• Huisman MH, de Jong SW, Verwiis MC, Schelhaas HJ, van der Kooi AJ, de Visser M, et al. Family history of neurodegenerative and vascular diseases in ALS: a population based study. Neurology. 2011;77:1363–9.
   PubMed Web of Science ®Google Scholar
• Fallis BA, Hardiman O. Aggregation of neurodegenerative disease in ALS kindreds. Amyotroph Lateral Scler. 2009; 10:95–8.
   PubMed Web of Science ®Google Scholar
• Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9ORF72 repeat expansion: a population based cohort study. Lancet Neurol. 2012;11:232–40.
   PubMed Web of Science ®Google Scholar
• van Blitterswijk M, DeJesus-Hernandez M, Rademakers R. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other non-coding repeat expansion disorders? Current Opinion Neurology. 2012;6:689–700.
   Google Scholar
• de Jong SW, Huisman MH, Sutedia NA, van der Koioi AJ, de Visser M, Schelhaas HJ, et al. Smoking, alcohol consumption and the risk of amyotrophic lateral sclerosis: a population based study. Amer J Epidemiol. 2012; epubub ahead of print.
   PubMedGoogle Scholar
• Paganoni S, Zhang M, Quiroz Zarate A, Jaffa M, Yu H, Cudkowicz ME, et al. Uric acid levels predict survival in males with amyotrophic lateral sclerosis. J Neurol 2012; epub ahead of print.
   Google Scholar
• Zoccolella S, Simone IL, Capozzo R, Tortelli R, Leo A, D’Errico E, et al. An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis. J Neurol. 2011;258:238–43.
   PubMed Web of Science ®Google Scholar
• Drory VE, Bronipolsky T, Artamonov I, Nefussy B. Influence of statins treatment on survival in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2008;273:81–3.
   PubMed Web of Science ®Google Scholar
• Nefussy B, Hirsch J, Cudkowicz ME, Drory VE. Gender based effect of statins on functional decline in amyotrophic lateral sclerosis. J Neurol Sci. 2011;300:23–7.
   PubMed Web of Science ®Google Scholar
• Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:74–82.
   Google Scholar
• Reiff DM, Spathis R, Chan CW. Inherited and somatic mitrochondrial DNA mutations in Guam amyotrophic lateral sclerosis and Parkinsonism-dementia. Neurol Sci. 2011;32:883–92.
   PubMed Web of Science ®Google Scholar
• Kihira T, Yoshida S, Kondo T, Iwai K, Wada S, Morinaga S, et al. An increase in ALS incidence on the Kii Peninsula, 1960 − 2009: a possible link to change in drinking water source. Amyotroph Lateral Scler. 2012;13: 347–50.
   PubMed Web of Science ®Google Scholar
• Ishiura H, Takahashi Y, Mitsui J, Yoshida S, Kihira T, Kokubo Y, et al. C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan. Arch Neurol. 2012;69:1154–8. Epub 2012/05/29. PubMed PMID: 22637429.
   PubMed Web of Science ®Google Scholar
• Sienko DG, Davis JP, Taylor JA, Brooks BR. Amyotrophic lateral sclerosis: a case-control study following detection of a cluster in a small Wisconsin community. Arch Neurol. 1990;47:38–41.
   PubMedGoogle Scholar